Duopharma Biotech Settles Lawsuit Without Admission of Liability

Bitget2026/10/19 10:23

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Duopharma Biotech's litigation ended in an amicable settlement with no admission of liability.
The plaintiff discontinued the suit on October 19, 2026, without permission to refile; no costs were awarded.
The High Court canceled the trial scheduled to begin that day.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duopharma Biotech Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3716316) on October 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Duopharma Biotech Settles Lawsuit Without Admission of Liability

You may also like

Crypto prices